NEUROFIBROMA PLEXIFORM
Clinical trials for NEUROFIBROMA PLEXIFORM explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMA PLEXIFORM trials appear
Sign up with your email to follow new studies for NEUROFIBROMA PLEXIFORM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested to shrink painful NF1 tumors
Disease control Recruiting nowThis early-stage study is testing a new oral medication called PAS-004 in adults with Neurofibromatosis Type 1 (NF1) who have painful, inoperable, or recurring plexiform neurofibroma tumors. The main goals are to find a safe dose, understand the side effects, and see if the drug …
Matched conditions: NEUROFIBROMA PLEXIFORM
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Post-Approval watch: tracking a nerve tumor drug in real patients
Disease control Recruiting nowThis study is observing patients in Korea who are already taking Koselugo for neurofibromatosis type 1 (NF1) and its associated nerve tumors. Its main purpose is to monitor the drug's safety and see how well it works in everyday medical practice, outside of a controlled clinical …
Matched conditions: NEUROFIBROMA PLEXIFORM
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for kids with tough cancers: early trial tests promising drug
Disease control Recruiting nowThis early-stage study is testing a drug called TURALIO in children and young adults (ages 3-35) whose cancers have returned or not responded to standard treatments. The main goals are to find the highest safe dose of the drug and understand its side effects. Participants will ta…
Matched conditions: NEUROFIBROMA PLEXIFORM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC